Patel Samir Rashmikant 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:00 pm Purchase | 2024-11-14 | 13D | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 5,745,834,167 10.850% | 2,332,672,000 (+68.34%) | Filing |
| 2024-06-07 6:00 pm Purchase | 2024-05-31 | 13D | Akari Therapeutics, Plc AKTX | Patel Samir Rashmikant | 3,413,162,167 14.500% | 3,413,162,167 (New Position) | Filing |